<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2023</volume><submitter>Peng B</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Necrotizing enterocolitis (NEC) and late-onset sepsis (LOS) are the major contributors to mortality and morbidity in preterm infants. This updated meta-analysis was aimed to assess the effects of mother's milk on the incidence of NEC, LOS, and other clinical outcomes in preterm infants.&lt;h4>Methods&lt;/h4>PubMed, Embase, and the Cochrane library were searched for papers published up to October 2022.&lt;h4>Results&lt;/h4>A total of 13 RCTs with 1330 infants were included in the final analysis. Significant difference in NEC (stage 2 or 3) was found between the intervention group and the control group (RR = 0.508, 95% CI: 0.314-0.822, and &lt;i>P&lt;/i>=0.008). The incidence of proven LOS (RR = 0.809, 95% CI: 0.610-1.071, and &lt;i>P&lt;/i>=0.139) and death (RR = 0.800, 95% CI: 0.571-1.122, and </pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pagination>7378064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10104743</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Oral Application of Mother's Own Milk for Reducing Necrotizing Enterocolitis in Preterm Infants: An Updated Meta-Analysis of RCTs.</pubmed_title><pmcid>PMC10104743</pmcid><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Qian J</pubmed_authors><pubmed_authors>Peng B</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Zheng B</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oral Application of Mother's Own Milk for Reducing Necrotizing Enterocolitis in Preterm Infants: An Updated Meta-Analysis of RCTs.</name><description>&lt;h4>Background&lt;/h4>Necrotizing enterocolitis (NEC) and late-onset sepsis (LOS) are the major contributors to mortality and morbidity in preterm infants. This updated meta-analysis was aimed to assess the effects of mother's milk on the incidence of NEC, LOS, and other clinical outcomes in preterm infants.&lt;h4>Methods&lt;/h4>PubMed, Embase, and the Cochrane library were searched for papers published up to October 2022.&lt;h4>Results&lt;/h4>A total of 13 RCTs with 1330 infants were included in the final analysis. Significant difference in NEC (stage 2 or 3) was found between the intervention group and the control group (RR = 0.508, 95% CI: 0.314-0.822, and &lt;i>P&lt;/i>=0.008). The incidence of proven LOS (RR = 0.809, 95% CI: 0.610-1.071, and &lt;i>P&lt;/i>=0.139) and death (RR = 0.800, 95% CI: 0.571-1.122, and </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T12:43:47.471Z</modification><creation>2025-04-04T12:43:47.471Z</creation></dates><accession>S-EPMC10104743</accession><cross_references><pubmed>37064945</pubmed><doi>10.1155/2023/7378064</doi></cross_references></HashMap>